Rapid Dose Therapeutics Corp ( (TSE:DOSE) ) just unveiled an update.
Rapid Dose Therapeutics Corp. announced its plan to issue common shares to satisfy the quarterly interest on its secured convertible notes, with an expected issuance by April 11, 2025. The company will issue 463,716 common shares at $0.20 per share to cover $92,745.22 in accrued interest. Additionally, the company is working towards closing a Shares for Debt Transaction by April 24, 2025, which involves issuing up to 1,600,000 common shares to settle outstanding debts with creditors. This move is part of RDT’s ongoing financial strategy to manage its obligations and strengthen its market position.
More about Rapid Dose Therapeutics Corp
Rapid Dose Therapeutics is a Canadian biotechnology company focused on revolutionizing drug delivery through innovative solutions. Their flagship product, QuickStrip™, is an orally dissolvable film that can be infused with various active ingredients, including nutraceuticals, pharmaceuticals, and vaccines, to ensure rapid absorption into the bloodstream.
YTD Price Performance: -9.09%
Average Trading Volume: 39,415
Technical Sentiment Signal: Buy
Current Market Cap: C$25.69M
See more insights into DOSE stock on TipRanks’ Stock Analysis page.